News
President Donald Trump incorrectly placed the blame for high prescription drug prices in the U.S. on foreign nations, making ...
7h
Zacks Investment Research on MSNGSK Inks $2B Deal With Boston Pharmaceuticals to Buy Liver Disease DrugGSK plc GSK announced that it has signed an agreement with Massachusetts-based biopharmaceutical company Boston ...
London: GSK plc and Boston Pharmaceuticals, a clinical stage biopharmaceutical company developing highly targeted therapies ...
The move comes as GSK faces pressure to replenish its pipeline, with some of its top-selling drugs nearing the end of their ...
DETROIT -- Detroit Tigers slugger Spencer Torkelson will get a day off on Wednesday night. The Tigers (28-15) wrap up a three ...
22h
RotoBaller on MSNSpencer Torkelson Resting Against Red SoxDetroit Tigers first baseman/designated hitter Spencer Torkelson is getting a breather in Wednesday's game against the ...
GSK will acquire the liver disease drug efimosfermin from Boston Pharmaceuticals in a deal worth up to $2 billion, The Wall Street Journal reported May 14. The agreement includes a $1.2 billion ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results